Evidence map›Paper›PMID 30092846›Full record

ArticleBreast cancer research : BCR2018

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Asra N Shaik, Julie J Ruterbusch, Eman Abdulfatah, Resha Shrestha, M H D Fayez Daaboul, Visakha Pardeshi, Daniel W Visscher, Sudeshna Bandyopadhyay, Rouba Ali-Fehmi, Michele L Cote

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Asra N ShaikDepartment of Oncology, Wayne State University School of Medicine, 4100 John R Street, MM04EP, Detroit, MI, 48201, USA.
Julie J RuterbuschDepartment of Oncology, Wayne State University School of Medicine, 4100 John R Street, MM04EP, Detroit, MI, 48201, USA.
Eman AbdulfatahDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Resha ShresthaDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
M H D Fayez DaaboulDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Visakha PardeshiDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Daniel W VisscherDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Sudeshna BandyopadhyayBarbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
Rouba Ali-FehmiDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI, USA.
Michele L CoteDepartment of Oncology, Wayne State University School of Medicine, 4100 John R Street, MM04EP, Detroit, MI, 48201, USA. cotem@karmanos.org.ORCID 0000-0003-0312-1601
Wayne State University · USMayo Clinic in Arizona · USThe Barbara Ann Karmanos Cancer Institute · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
NCI NIH HHS 1F31CA22133301NCI NIH HHS P30 CA022453
6 · The paper itself

Abstract

backgroundFibroadenomas are common benign breast lesions, and studies of European American women indicate a persistent, increased risk of breast cancer after diagnosing a fibroadenoma on biopsy. This association has not been independently assessed in African American women, despite reports that these women are more likely to present with fibroadenomas.

methodsThe study cohort included 3853 African American women with a breast biopsy completed between 1997 and 2010 in metropolitan Detroit. Biopsies were microscopically reviewed for benign breast lesions, including fibroadenoma, proliferative disease, and atypia. Risk of breast cancer within the cohort was estimated using relative risk ratios and 95% CIs calculated using multivariable log-binomial regression. Relative risk of breast cancer in this cohort compared with African American women in the broader metropolitan Detroit population was estimated using standardized incidence ratios (SIRs).

resultsFibroadenomas occurred more frequently in biopsies of younger women, and other types of benign breast lesions were less likely to occur when a fibroadenoma was present (p = 0.008 for lobular hyperplasia; all other p values < 0.01). Unlike women with other benign lesions (SIR, 1.41; 95% CI, 1.20, 1.66), women with fibroadenomas did not have an increased risk of developing breast cancer compared with the general population (SIR, 0.94; 95% CI, 0.75, 1.18). Biopsies that indicated a fibroadenoma were associated with a reduced risk of breast cancer after adjusting for age at biopsy, proliferation, and atypia (relative risk, 0.67; 95% CI, 0.48, 0.93) compared with biopsies without a fibroadenoma.

conclusionsThese findings have important implications for breast cancer risk models and clinical assessment, particularly among African American women, in whom fibroadenomas are common.

Indexed as

AdultAgedAge FactorsBiopsyBlack or African AmericanBreastBreast NeoplasmsCohort StudiesFemaleFibroadenomaHumansIncidenceMiddle AgedRisk FactorsAfrican AmericanBenign breast diseaseBreast cancerRisk

Identifiers

PMID30092846
PMCPMC6085691
OpenAlexW2886129990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.